Abstract
ABSTRACTBackgroundInsulin Resistance (IR) affects a quarter of the world’s adult population and is a major factor in the pathogenesis of cardio-metabolic disease. Non-invasive sampling of exhaled breath contains metabolic markers indicative of underlying systemic metabolic abnormality.MethodIn this pilot study, we implemented a non-invasive breathomics approach, combined with random forest machine learning, to investigate metabolic markers from pre-diabetic Hispanic adolescents with obesity as indicators of abnormal metabolic regulation.FindingsExhaled breath collection using the ReCIVA breathalyzer is feasible in an adolescent population. We have identified a signature of breath metabolites (breath-IR model) which correlates with Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (R = 0.95, p <0.001). A strong correlation was also observed between the breath-IR model and the blood glycemic profile (fasting insulin R=0.91, p <0.001 and fasting glucose R=0.80, p <0.001). Among tentatively identified metabolites, limonene, undecane, and 2,7-dimethyl-undecane, significantly cluster individuals based on HOMA-IR (p =0.003, p =0.002, and p<0.001, respectively). Our breath-IR model differentiates between adolescents with and without IR with an area under the receiver operating characteristic curve of 0.87, after cross-validation.InterpretationIdentification of a breath metabolite signature indicative of IR in prediabetic Hispanic adolescents with obesity provides evidence of the utility of exhaled breath metabolomics for assessing systemic metabolic dysregulation. A simple and non-invasive breath-based test has utility as a diagnostic tool for monitoring IR progression, potentially allowing for earlier detection of IR and implementation of early interventions to prevent onset of type 2 diabetes mellitus.FundingThis study was funded by The Healthy Babies Project, Texas Biomedical Research Institute, San Antonio, TX.
Publisher
Cold Spring Harbor Laboratory
Reference71 articles.
1. Association between insulin resistance and the development of cardiovascular disease;Cardiovascular Diabetology,2018
2. The role of insulin resistance in nonalcoholic fatty liver disease;The Journal of Clinical Endocrinology & Metabolism,2006
3. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD;American Journal of Kidney Diseases,2020
4. Population-Based Studies on the Epidemiology of Insulin Resistance in Children;Journal of Diabetes Research,2015
5. CDC (Centers for Disease Control and Prevention). Prevalence of Obesity Among Adults and Youth: United States. 2017; https://www.cdc.gov/nchs/data/databriefs/db288.pdf.